Trovagene (TROV) Announces Equity Investment of $1.5 Million – StreetInsider.com
Trovagene (TROV) Announces Equity Investment of $1.5 Million StreetInsider.com
Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company, using a precision medicine approach to develop drugs that target cell division …
Source: Investment New Feed